FGFR4 and cystic fibrosis: We show that MAPK p38 signaling regulates cellular senescence in the CF bronchial epithelium and seems to involve FGFR4 and partially FGFR1, making FGFR blockade a novel and potential future amenable therapeutic target for senolytic therapies targeting the CF lung, which is independent of CFTR function.